Depressive symptoms in Parkinson's disease are related to decreased hippocampus and amygdala volume

Depression and anxiety are common in Parkinson's disease (PD), and are among the non‐motor symptoms that interfere with quality of life dramatically. Motor, cognitive, and affective features overlap in PD, hampering diagnosis. To shed more light on the contribution of structural brain changes to the presence of PD‐related depressive symptoms, we conducted a Voxel‐Based Morphometry (VBM) study. We hypothesized that depressive symptoms in PD are related to regional gray matter (GM) volume loss within the limbic circuit. We analyzed the T1‐weigthed magnetic resonance imaging (MRI) images of 67 PD patients with a mean disease duration of 2.95 (±3.39) years. Scores on the Beck Depression Inventory (BDI) and GM probability maps were analyzed by regression analysis to study the association between GM volume and severity of depressive symptoms. Results are reported at both the uncorrected and the family‐wise error (FWE) corrected level for multiple comparisons. The BDI scores correlated negatively with bilateral hippocampus and right amygdala volume and positively with the volume of the anterior cingulate cortex. These findings confirm the hypothesized involvement of the limbic circuit in PD‐related depressive symptoms. We speculate that non‐dopaminergic changes are essential in the pathophysiology of depressive symptoms in PD, because our findings suggest the involvement of extra‐striatal brain regions. © 2015 International Parkinson and Movement Disorder Society

[1]  A. Aleman,et al.  Regional brain volume in depression and anxiety disorders. , 2010, Archives of general psychiatry.

[2]  James T Becker,et al.  Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration. , 2002, The American journal of psychiatry.

[3]  M. Schocke,et al.  Pattern of brain atrophy in elderly patients with depression revealed by voxel-based morphometry , 2008, Psychiatry Research: Neuroimaging.

[4]  Dick J Veltman,et al.  Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[5]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[6]  P. Andersen,et al.  Major depressive disorder in Parkinson's disease: a register‐based study , 2002, Acta psychiatrica Scandinavica.

[7]  Nora Turjanski,et al.  Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. , 2005, Brain : a journal of neurology.

[8]  D. Aarsland,et al.  The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson’s disease , 2009, Journal of Neurology, Neurosurgery, and Psychiatry.

[9]  Dag Aarsland,et al.  Depression in Parkinson disease—epidemiology, mechanisms and management , 2011, Nature Reviews Neurology.

[10]  Minjie Wu,et al.  Gray Matter Changes in Late Life Depression—a Structural MRI Analysis , 2008, Neuropsychopharmacology.

[11]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[12]  E. Tolosa,et al.  Hippocampal head atrophy predominance in Parkinson’s disease with hallucinations and with dementia , 2008, Journal of Neurology.

[13]  T. Shallice,et al.  Human cingulate cortex and autonomic control: converging neuroimaging and clinical evidence. , 2003, Brain : a journal of neurology.

[14]  M. Lapeyre-Mestre,et al.  Anxious and depressive symptoms in Parkinson's disease: The French cross‐sectionnal DoPaMiP study , 2010, Movement disorders : official journal of the Movement Disorder Society.

[15]  Dennis Velakoulis,et al.  Variability of the paracingulate sulcus and morphometry of the medial frontal cortex: Associations with cortical thickness, surface area, volume, and sulcal depth , 2008, Human brain mapping.

[16]  A. Schrag,et al.  Psychosis, apathy, depression and anxiety in Parkinson's disease , 2012, Neurobiology of Disease.

[17]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[18]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[19]  D. Brooks,et al.  Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures , 2010, Neurology.

[20]  Dennis Velakoulis,et al.  The influence of sulcal variability on morphometry of the human anterior cingulate and paracingulate cortex , 2006, NeuroImage.

[21]  João Ricardo Sato,et al.  Depression in Parkinson's disease: Convergence from voxel-based morphometry and functional magnetic resonance imaging in the limbic thalamus , 2009, NeuroImage.

[22]  I. Katz,et al.  Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  James R MacFall,et al.  Hippocampal volume in geriatric depression , 2000, Biological Psychiatry.

[24]  G. Halliday,et al.  Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. , 2002, Brain : a journal of neurology.

[25]  R. Camicioli,et al.  Intact limbic-prefrontal connections and reduced amygdala volumes in Parkinson's disease with mild depressive symptoms. , 2012, Parkinsonism & related disorders.

[26]  H. Adami,et al.  Epidemiology and etiology of Parkinson’s disease: a review of the evidence , 2011, European Journal of Epidemiology.

[27]  Y. Liu,et al.  Apathy, depression, and motor symptoms have distinct and separable resting activity patterns in idiopathic Parkinson disease , 2013, NeuroImage.

[28]  H. Braak,et al.  Dysfunction of the locus coeruleus–norepinephrine system and related circuitry in Parkinson's disease-related dementia , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[29]  Z. Illés,et al.  Morphometric changes of gray matter in Parkinson's disease with depression: A voxel‐based morphometry study , 2008, Movement disorders : official journal of the Movement Disorder Society.

[30]  W. Taylor,et al.  Amygdala volume in late-life depression: relationship with age of onset. , 2011, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[31]  D. Aarsland,et al.  A systematic review of prevalence studies of depression in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[32]  F. Verhey,et al.  The validity of the Beck Depression Inventory as a screening and diagnostic instrument for depression in patients with Parkinson's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.

[33]  Massimo Filippi,et al.  Neuroanatomical correlates of depression and apathy in Parkinson's disease: Magnetic resonance imaging studies , 2011, Journal of the Neurological Sciences.

[34]  William W. McDonald,et al.  Provisional diagnostic criteria for depression in Parkinson's disease: Report of an NINDS/NIMH Work Group , 2006, Movement disorders : official journal of the Movement Disorder Society.

[35]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[36]  A. Beck,et al.  An inventory for measuring clinical anxiety: psychometric properties. , 1988, Journal of consulting and clinical psychology.

[37]  J. Larsen,et al.  Health related quality of life in Parkinson's disease: a prospective longitudinal study , 2000, Journal of neurology, neurosurgery, and psychiatry.

[38]  L. Tremblay,et al.  Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[39]  I. McKeith,et al.  Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. , 2004, Brain : a journal of neurology.

[40]  K. Dujardin,et al.  Symptomatology and markers of anxiety disorders in Parkinson's disease: A cross‐sectional study , 2011, Movement disorders : official journal of the Movement Disorder Society.

[41]  L. Yao,et al.  Abnormal Baseline Brain Activity in Non-Depressed Parkinson’s Disease and Depressed Parkinson’s Disease: A Resting-State Functional Magnetic Resonance Imaging Study , 2013, PloS one.

[42]  Alan J. Thomas,et al.  Cortical thickness and VBM-DARTEL in late-life depression. , 2011, Journal of affective disorders.

[43]  R. Kahn,et al.  Cortical thickness and voxel-based morphometry in depressed elderly , 2010, European Neuropsychopharmacology.

[44]  P. Calabresi,et al.  New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease , 2013, The Lancet Neurology.

[45]  Andrew H. Miller,et al.  Cytokines and Glucocorticoid Receptor Signaling , 2009, Annals of the New York Academy of Sciences.

[46]  John Ashburner,et al.  A fast diffeomorphic image registration algorithm , 2007, NeuroImage.

[47]  W. Drevets.  Neuroimaging studies of mood disorders , 2000, Biological Psychiatry.

[48]  A. Simmons,et al.  Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder. , 2011, Archives of general psychiatry.

[49]  E. Masliah,et al.  Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model , 2012, The European journal of neuroscience.

[50]  H. Braak,et al.  Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen , 2003, Journal of Neural Transmission.